Lexie Lumen vs Otofonix Groove

The Lexie Lumen is a budget-priced OTC hearing aid available for $299, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This behind-the-ear device ranks #40 among 65 OTC hearing aids tested, placing it in the top 60% of its category. In our testing, the Lumen demonstrates mixed speech performance. Speech in quiet scores 2.5/5, falling 0.24 points below the category average. Speech in noise performs better at 2.0/5, which is 0.55 points above the category average—though this remains mixed in absolute terms. Where the device excels is feedback handling, achieving a perfect 5.0/5, which is 0.46 points above the already-strong category average of 4.54/5. The most significant limitation is music streaming, which scores 0.0/5—a full 1.92 points below the category average. Users who prioritize streaming audio from their phones should look elsewhere. The device uses disposable batteries rather than rechargeables. At this price point, buyers face a competitive landscape. Several alternatives in the same price range deliver substantially higher scores, with some reaching into the 4.2-4.7 range. The Lexie Lumen may suit budget-conscious consumers who prioritize stable, feedback-free amplification over streaming capabilities and don't require top-tier speech clarity. However, those willing to explore other options at similar prices may find significantly better overall performance.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.